Ask Michael Burke Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Langemak who wrote (71314)	12/2/1999 6:04:00 PM
From: Knighty Tin	Read Replies (1) of 132070

Dave, The smaller biotechs certainly deserve some recognition, though I think they may still be blasted when the general market crashes. I punted all of my Incyte today and one third of my Medarex. I am holding the other 2/3s hoping for a quadruple, as my average cost was about $4. It is sure nice to see some of these long-suffering issues, Medarex much more so than Incyte, hit the jackpot. Funny story. A couple of years ago we had a threadster named Robin who laughed when I told her I did research for a living. She dared me to produce a research report on the thread. Though I usually ignore such taunts, I had a report on Medarex handy that I had unsuccessfully tried to hawk to a value hedge fund. Now, a fourple in two years is certainly not spectacular in this mania, but I'll take one every time on a value stock. <g>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next